211 related articles for article (PubMed ID: 17387385)
1. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.
Kiss J; Tímár J; Somlai B; Gilde K; Fejôs Z; Gaudi I; Ladányi A
Pathol Oncol Res; 2007; 13(1):21-31. PubMed ID: 17387385
[TBL] [Abstract][Full Text] [Related]
2. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
Kiss J
Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
4. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
5. The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment.
Zidlik V; Brychtova S; Uvirova M; Ziak D; Dvorackova J
Int J Mol Sci; 2015 Apr; 16(4):7876-89. PubMed ID: 25913374
[TBL] [Abstract][Full Text] [Related]
6. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
[TBL] [Abstract][Full Text] [Related]
7. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of tumor-infiltrating immune cells in melanoma].
Ladányi A
Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
[TBL] [Abstract][Full Text] [Related]
10. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients.
De Logu F; Galli F; Nassini R; Ugolini F; Simi S; Cossa M; Miracco C; Gianatti A; De Giorgi V; Rulli E; Cossu A; Massi D; Mandalà M
Cells; 2021 Feb; 10(2):. PubMed ID: 33671367
[TBL] [Abstract][Full Text] [Related]
11. Correlation with lymphocyte infiltration, but lack of prognostic significance of MECA-79-positive high endothelial venules in primary malignant melanoma.
Sebestyén T; Mohos A; Liszkay G; Somlai B; Gaudi I; Ladányi A
Melanoma Res; 2018 Aug; 28(4):304-310. PubMed ID: 29683859
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
Krishna Y; McCarthy C; Kalirai H; Coupland SE
Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
[TBL] [Abstract][Full Text] [Related]
13. The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?
Obeid JM; Hu Y; Erdag G; Leick KM; Slingluff CL
Melanoma Res; 2017 Jun; 27(3):211-217. PubMed ID: 28118270
[TBL] [Abstract][Full Text] [Related]
14. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell density and activation status of tumour-infiltrating lymphocytes in metastatic human melanoma: possible implications for sentinel node metastases.
Barbour AH; Coventry BJ
Melanoma Res; 2003 Jun; 13(3):263-9. PubMed ID: 12777981
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
19. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance.
Döme B; Paku S; Somlai B; Tímár J
J Pathol; 2002 Jul; 197(3):355-62. PubMed ID: 12115882
[TBL] [Abstract][Full Text] [Related]
20. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
